Managed alcohol program
Managed Alcohol Program (MAP) is a harm reduction strategy aimed at people who are chronically alcohol-dependent and have experienced repeated unsuccessful attempts at abstinence. These programs provide a regulated quantity of alcohol to participants in a controlled environment to reduce the harms associated with severe alcohol dependence and high-risk drinking behaviors.
History[edit]
The concept of Managed Alcohol Programs originated in the late 20th century as a response to the growing problem of chronic alcoholism and the associated social and health issues. The first MAP was established in Toronto, Canada in 1996, and since then, similar programs have been implemented in various parts of the world.
Program Structure[edit]
Managed Alcohol Programs typically involve the provision of a prescribed amount of alcohol at regular intervals throughout the day. The alcohol provided is often a safer alternative to the non-beverage alcohol (such as mouthwash or hand sanitizer) that participants may otherwise consume. In addition to alcohol provision, MAPs often include a range of support services such as housing, healthcare, counseling, and social support.
Effectiveness[edit]
Research on the effectiveness of Managed Alcohol Programs is ongoing, but early studies suggest that these programs can lead to improvements in health and social outcomes for participants. These may include reductions in alcohol-related harm, improvements in physical and mental health, and increased stability in housing and social relationships.
Criticism[edit]
Despite the potential benefits, Managed Alcohol Programs have faced criticism. Some argue that these programs enable harmful behavior by providing alcohol to people with severe dependence. Others express concern about the potential for misuse or exploitation of participants.
See Also[edit]
| Health care | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
